Fact sheet: EDRFGblHlthcr

Fund information

Fund name
EDRF Global Healthcare R EUR
Fund company manager
Edmond de Rothschild Asset Man
Fund type
SIB
Fund manager
Valerie Guelfi
since 02/09/2016
Fund objective
The objective is to grow net assets by investing in companies operating in the healthcare sector, over the recommended investment period.
Benchmark
MSCI AC World Health Care
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

4.28 %

1 Year rank in sector

22/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 488.4 m

FE Risk score

154

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    73.6%
  • Europe
    22.5%
  • Asia Pacific ex Japan
    2.4%
  • Money Market
    1.5%
  • Biotechnology/Medical
    43.3%
  • Pharmaceuticals
    33.2%
  • Health Care
    11%
  • Healthcare & Medical Products
    11%
  • Money Market
    1.5%
  • North American Equities
    73.6%
  • European Equities
    22.5%
  • Asia Pacific ex Japan Equities
    2.4%
  • Money Market
    1.5%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund5.21 %-1.84 %4.28 %24.85 %96.17 %
Sector4.55 %4.06 %9.29 %21.02 %98.78 %
Rank within sector12 / 3025 / 3022 / 299 / 2712 / 23
Quartile th2 nd4 th4 th2 nd3 rd

Calendar performance

YTD-20172016201520142013
Fund3.86 %-8.06 %19.28 %36.28 %26.28 %
Sector16.03 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector26 / 2912 / 292 / 277 / 2421 / 23
Quartile th4 th2 nd1 st2 nd4 th

Risk statistics

Alpha1.8
Beta0.96
Sharpe0.32
Volatility16.45
Tracking error7.41
Information ratio0.18
R-Squared0.8

Price movement

52 week high336.21
52 week low277.16
Current bid price0
Current offer price0
Current mid price319.82

Holdings by region

  • 73.6% North America
  • 22.5% Europe
  • 2.4% Asia Pacific ex Japan
  • 1.5% Money Market

Holdings by sector

  • 43.3% Biotechnology/Medical
  • 33.2% Pharmaceuticals
  • 11% Health Care
  • 11% Healthcare & Medical Products
  • 1.5% Money Market

Holdings by asset type

  • 73.6% North American Equities
  • 22.5% European Equities
  • 2.4% Asia Pacific ex Japan Equities
  • 1.5% Money Market

Individual holdings

  • 6.1% CELGENE CORP
  • 5.9% ALLERGAN PLC
  • 5.7% GILEAD SCIENCES INC
  • 4.9% PFIZER INC
  • 4.4% GENMAB AS